UMIN ID: UMIN000000519
Registered date:30/11/2006
A prospective study:the clinical value of acidosis correction by acetate free biofiltration (AFB) in hemodialysis patients.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Dysdialysis syndrome |
Date of first enrollment | 2006/11/01 |
Target sample size | 30 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | 1)Hemodiafiltration(HDF) 2)AFB(bicarbonate high control) 3)AFB(bicarbonate low control) |
Outcome(s)
Primary Outcome | Efficacy (1)stabilization of circulation dynamics (2)improvement of QOL (3)correction of acidosis (4)rHuEPO dosage |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | (1)chronic inflammation, malignant disorder, severe respiratory organs and liver disorder, heart failure (2)20 years or older. (3)participating in another clinical trial for 12 weeks or longer. (4)pregnant, during the nursing, possibly pregnant and having the hope of child bearing. (5)judged inappropriate as study subject by the investigator. |
Related Information
Primary Sponsor | Showa University of Medicine Department of Nephrology |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Showa University of Medicine Department of Nephrology |
Secondary ID(s) |
Contact
public contact | |
Name | Hirokazu Honda |
Address | Japan |
Telephone | |
Affiliation | Showa University of Medicine Department of Nephrology |
scientific contact | |
Name | Tadao Akizawa |
Address | 1-5-8 hatano-dai, sinagawa, tokyo Japan |
Telephone | |
Affiliation | Showa University of Medicine Department of Nephrology |